SCHEMBL1818362

SCHEMBL1818362

N#Cc1cc(-c2ccc3c(c2)N(S(=O)(=O)c2ccc(N)nc2)CCO3)cs1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PIK3CA P42336 1/20 0.40
▸ CYP2C9 P11712 1/20 0.37
▸ MEN1 O00255 2/20 0.36
▸ KMT2A Q03164 2/20 0.36
▸ SCN9A Q15858 4/20 0.36
▸ SCN5A Q14524 3/20 0.36
▸ ALDH1A1 P00352 2/20 0.35
▸ PKM P14618 2/20 0.35
▸ PKLR P30613 1/20 0.35
▸ GCK P35557 1/20 0.35
▸ PDE3B Q13370 2/20 0.35
▸ PDE3A Q14432 2/20 0.35
▸ RIPK2 O43353 1/20 0.35
▸ NOD2 Q9HC29 1/20 0.35
▸ CPT1A P50416 3/20 0.35
▸ CPT1B Q92523 3/20 0.35
▸ NPC1 O15118 1/20 0.35
▸ KDM4E B2RXH2 1/20 0.34
▸ LMNA P02545 1/20 0.34
▸ HSD17B10 Q99714 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1819206 0.88 PKM (0.42) CYP2C9MEN1KMT2ASCN9ASCN5A
SCHEMBL1818351 0.87 PIK3CA (0.39) PIK3CACYP2C9MEN1KMT2AALDH1A1
SCHEMBL1815092 0.87 MEN1 (0.38) CYP2C9MEN1KMT2ASCN9ASCN5A
SCHEMBL1816305 0.87 CYP2C9 (0.37) CYP2C9MEN1KMT2ASCN9ASCN5A
SCHEMBL1820266 0.87 MEN1 (0.39) CYP2C9MEN1KMT2ASCN9ASCN5A
SCHEMBL1821637 0.87 PKM (0.48) CYP2C9MEN1KMT2AALDH1A1PKM
SCHEMBL1817952 0.84 CYP11B1 (0.44) CYP2C9CPT1ACPT1B
SCHEMBL1816941 0.84 CYP2C9 (0.53) CYP2C9MEN1KMT2AALDH1A1PKM
SCHEMBL1817593 0.84 NR1H3 (0.46) CYP2C9MEN1KMT2AALDH1A1PKM
SCHEMBL1816640 0.82 PKM (0.41) PIK3CACYP2C9MEN1KMT2ASCN9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011057892-A1 2,3-DIHYDROBENZOXAZINE AND 2,3-DIHYDROBENZOTHIAZINE DERIVATES AS HIF-INHIBITORS FOR THE TREATMENT OF CANCER AND INFLAMMATORY DISEASES ELARA PHARMACEUTICALS GMBH (DE) 2011-05-19 — — WO claimed
WO-2011057892-A1 2,3-DIHYDROBENZOXAZINE AND 2,3-DIHYDROBENZOTHIAZINE DERIVATES AS HIF-INHIBITORS FOR THE TREATMENT OF CANCER AND INFLAMMATORY DISEASES ELARA PHARMACEUTICALS GMBH (DE) 2011-05-19 — — WO disclosed
Send feedback